Cargando…
Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B
Geranylgeranyltransferase type-I (GGTase-I) represents an important drug target since it contributes to the function of many proteins that are involved in tumor development and metastasis. This led to the development of GGTase-I inhibitors as anti-cancer drugs blocking the protein function and membr...
Autores principales: | Hinz, Sonja, Jung, Dominik, Hauert, Dorota, Bachmann, Hagen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958859/ https://www.ncbi.nlm.nih.gov/pubmed/33801503 http://dx.doi.org/10.3390/ijms22052501 |
Ejemplares similares
-
Geranylgeranyltransferase I is essential for dendritic development of cerebellar Purkinje cells
por: Wu, Kong-Yan, et al.
Publicado: (2010) -
Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I
por: Chan, Lai N., et al.
Publicado: (2011) -
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012) -
GGTase3 is a Newly Identified Geranylgeranyltransferase Targeting a Ubiquitin Ligase
por: Kuchay, Shafi, et al.
Publicado: (2019) -
Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells
por: Lu, Jie, et al.
Publicado: (2015)